Medically reviewed by Dr. Spencer Richlin
AI and robotics are changing what's possible in IVF — making treatment safer, more precise, and more personalized. But these tools are only as good as the experts behind them. Read on to discover what they can (and can't) do, and the questions every patient should be asking.
In this article:
- Inside the Lab: Protecting Your Specimens
- RI Witness: Digital Safety Checks at Every Step
- TMRW: The Smarter Cryostorage Option
- Cycle Clarity: Smarter Follicle Counts, Every Scan
- How AI Can Help Identify Viable Embryos
- How does AI compare to human embryologists?
- Why Human Expertise Matters More Than Ever
- The Future of Fertility Treatment
- Addressing Common Concerns About AI
- Illume's Approach: Innovation with Integrity
At Illume Fertility, we're thoughtfully integrating artificial intelligence, robotics, and advanced genetic testing into patient care. Think of these tools as smart assistants: powerful, but always guided by the physicians, nurses, and embryologists who know you best.
And to answer the question we hear most often — no, AI will never replace your doctor.
Fertility treatment involves some of the most delicate, high-stakes processes in modern medicine. The eggs, embryos, and sperm entrusted to our lab deserve more than careful hands — they deserve systems built specifically to protect them.
At Illume Fertility, we've invested in innovative technologies that reduce risk, improve accuracy, and give you greater confidence throughout treatment.
Imagine if every dish and tube in the IVF lab had a digital fingerprint that gets checked automatically, all day long. That's what RI Witness does.
This system uses radio-frequency identification (RFID) to track all lab equipment that holds your samples. This technology is similar to how you might tap to pay at a coffee shop. Small tags placed on each dish create a unique identity, and sensors throughout the lab verify everything matches up correctly.
If something doesn't match (for example, if two patients' samples get too close) the system immediately sounds an alarm and flashes warning lights. The embryologist must stop, check, and verify the issue has been resolved before work can continue.
RI Witness never works alone. Experienced embryologists oversee every step, review every alert, and make all final decisions. The technology acts as an extra set of eyes that never blinks, but skilled humans remain in charge. For most procedures and identification steps, there is also a second human witness requirement alongside the system.
RI Witness also tracks and creates a timestamped report for each procedure, offering a precise record of exactly when and where your eggs, embryos, and/or sperm have been.
Beyond the obvious security improvements, RI Witness also offers:
In a study of 408 IVF patients, 97% reported feeling highly comfortable at a clinic using an electronic witnessing system — a finding supported by subsequent research showing improvements in traceability, error reduction, and embryologist confidence.
Traditional cryostorage relied solely on handwritten labels and paper records — a system that is vulnerable to human error. TMRW changes this completely.
This FDA-cleared robotic system can store frozen eggs, embryos, and sperm with digital tracking that tells you exactly where your specimens are at any time. Each specimen is stored in a special beacon that connects to a secure, HIPAA-compliant system accessible to you and your care team.
Behind the scenes, TMRW's Overwatch team monitors thousands of data points every day, checking temperatures constantly with backup power in place for emergencies. Our experts at Illume Fertility are also always monitoring the system, ready to act if anything seems off.
TMRW reduces potential failure points by 94% compared to manual systems, with 24/7 security, advanced monitoring, and automated robotics — all while keeping your specimens nearby and easy to access when you need them.
Monitoring appointments are one of the most frequent (and most important) parts of an IVF or IUI cycle. During these visits, your care team tracks how the follicles are growing and responding to medication, using that information to guide decisions about your treatment.
Cycle Clarity is AI software that works in the background during ultrasounds, automatically identifying, measuring, and counting follicles as your scan takes place. Instead of relying solely on manual counting, Cycle Clarity processes each image and delivers consistent, accurate results every time.
For patients, this means less time in the exam room during an already demanding process.
For your care team, it means reliable data they can act on with confidence — and a clearer picture of where you are in your cycle at any given moment.
Beyond individual scans, Cycle Clarity gives our clinical team valuable insight across the practice. It can flag how many patients are approaching a hormonal "surge" simultaneously and predict follicle counts ahead of time, allowing the team to plan and prioritize care at the moments that matter most.
A Note on Cost
You may be wondering whether these technologies come with added costs. At Illume, innovations like RI Witness, TMRW, and Cycle Clarity are part of our standard care — not add-ons you need to request or pay extra for. We believe all patients deserve the highest standards of safety and accuracy.
For decades, embryologists have evaluated embryos under microscopes, grading them based on appearance to determine which are most likely to lead to a successful pregnancy — a method that hasn't changed much since the first IVF baby was born in 1978.
The challenge is that even experienced embryologists can interpret the same embryo differently, and the human eye can miss subtle developmental patterns that may matter.
AI is beginning to change this.
Here's how technology can support the process:
This technology also allows embryologists to pinpoint the stage where embryo development may have deviated from normal, which can provide helpful insights.
[cta1]
A 2024 study published in Nature Medicine — spanning 14 IVF clinics across Australia and Europe — found that an AI algorithm wasn't yet as accurate as experienced embryologists when it came to selecting embryos most likely to lead to a successful pregnancy.
A separate editorial in the same journal noted that the hype around AI in embryo selection often runs ahead of what the evidence actually supports. That said, the study did find that AI meaningfully reduced the time embryologists spent manually evaluating embryos — suggesting a real role in supporting the process, even if it isn't ready to lead it.
Large clinical trials have similarly found that time-lapse imaging alone doesn't significantly increase live birth rates compared to standard embryo culture. The full impact of AI on IVF outcomes is still being confirmed through research, and we won't overstate what it can do.
At Illume, we are actively exploring time-lapse technology and plan to introduce it in the near future. As with all new tools, we will implement it only when we're confident it meets our standards for safety and patient benefit.
For patients who choose to pursue preimplantation genetic testing (PGT), AI may already be playing a role in how your results are analyzed. PGT involves biopsying an embryo to screen for chromosomal abnormalities, inherited genetic conditions, or structural chromosome changes before transfer — some of the most consequential data points in the IVF process.
Some genetic testing platforms now apply machine learning to that data, cross-referencing results against large datasets of embryos with known outcomes to improve accuracy and reduce misclassification.
The practical impact: fewer chromosomally normal embryos being incorrectly flagged as abnormal, and greater confidence when an embryo is cleared for transfer.
About 30% of fertility challenges involve male factors, yet sperm analysis has historically been one of the more subjective parts of the diagnostic process.
Researchers at Columbia University developed the STAR (Sperm Tracking and Recovery) system, which uses AI to identify viable sperm in samples where conventional methods had found none — even after days of searching.
One couple conceived after 18 years of trying once STAR identified sperm that had previously been missed. While STAR is not currently available at Illume, it represents one of the more meaningful examples of AI solving a problem that human analysis alone could not.
As powerful as these tools are, they're only part of the story. Technology can enhance fertility treatment, but it can't replace the people at the center of it.
At Illume Fertility, our physicians, nurses, medical assistants, embryologists, andrologists, genetic counselors, and Integrated Fertility & Wellness providers collaborate to deliver the kind of care no algorithm can replicate — from complex diagnostic work to emotional support to helping you navigate some of the hardest decisions of your life.
The bottom line: AI can suggest tests or flag patterns, but knowing which questions to ask and which threads to pull will always require real human judgment.
Many fertility challenges involve multiple overlapping causes.
When a patient has experienced failed cycles or recurrent pregnancy loss, our physicians don't simply repeat the same protocols — they carefully investigate each and every case. That means asking the right questions, ordering appropriate tests, and connecting information across different body systems.
This approach sometimes surfaces treatable conditions (such as thyroid imbalances, vitamin deficiencies, hormonal disorders, or autoimmune factors) that previous evaluations missed by focusing too narrowly on reproductive organs alone.
Navigating infertility and the family-building process is hard in ways that are difficult to put into words. Feelings of guilt, shame, and isolation are common — particularly when patients don't understand why treatment isn't working.
No technology can provide what you need most in those moments: to feel genuinely heard.
That's why Illume prioritizes whole-patient care from the start, offering in-house acupuncture, nutrition counseling, support groups, fertility-focused yoga, and mental health referrals through our Integrated Fertility & Wellness program.
One of the toughest decisions in fertility treatment is knowing how long to keep trying. Making the best call means weighing medical realities alongside emotional reserves, financial resources, and deeply personal values – something no AI tool can do for you.
A fertility specialist's role isn't to tell you what to do. It's to make sure you fully understand your options and feel supported in whatever path makes sense for your life – whether that's continuing treatment, exploring donor conception, pursuing adoption, or building a life without children.
At Illume, we believe that good care means honoring that there's no single right answer.
With declining fertility rates, increased awareness of reproductive options, and more people delaying parenthood into their 30s and 40s, the field will continue to grow and evolve.
A few promising areas of research include non-invasive genetic testing that doesn't require embryo biopsy, improved AI models that better predict treatment success and personalize medication protocols, technologies to assess egg quality, and a better understanding of immune factors in implantation failure.
Exciting as these developments are, promise isn't the same as proof. Our team only integrates tools that have been rigorously validated and demonstrated real benefit across diverse patient populations — and that standard doesn't waver regardless of what's generating buzz in the field.
[cta2]
While new technologies can offer hope and improve outcomes, many patients have legitimate concerns about the use of AI in fertility treatment. Here are our honest answers to some of the most frequently asked questions:
Yes. All AI systems used at Illume Fertility comply with strict HIPAA privacy regulations. Your data is never shared without your explicit permission, never sold to third parties, and never used to train outside AI models without your knowledge.
You always control who can access your information — and if you ever have questions about how a specific tool handles your data, our team is happy to walk you through it.
In the medical field, financial incentives can sometimes drive unnecessary treatments.
At Illume, clinical decisions are based on medical evidence and patient wellbeing — not volume targets. Sometimes the right path forward is a different protocol, an alternative approach, or simply taking a break. Our goal is always what's best for you.
Not always — and we think it's important to be upfront about that. AI systems learn from the data they're trained on, so if that data lacks diversity, the technology may perform better for some groups than others.
We monitor research on AI performance across different populations and only implement tools that have been validated across diverse patient groups. This is an ongoing concern across the field, and one we take seriously.
Some promising research is underway (including studies exploring whether certain medications might slow ovarian aging) but these are early-stage findings, not established treatments. Your doctor will always help you understand your specific situation, set realistic expectations, and make decisions based on your overall health.
At Illume, advanced technology and expert human care aren't in competition — they work together. Systems like RI Witness and TMRW provide automated safeguards while trained professionals oversee every step. AI-assisted tools give your care team better data to act on. And new technologies are only introduced when the evidence genuinely supports them.
For those who have faced months or years of negative pregnancy tests or painful losses, these tools can offer fresh approaches and renewed hope.
We believe technology is only as good as the hands and hearts that guide it. Behind every system and every algorithm are dedicated healthcare professionals who bring expertise, empathy, and wisdom to your care — and that will never change.
This article is for informational purposes only and does not constitute medical advice. Always discuss your personal situation and treatment options with your doctor.